Therapeutic efficacy of a four-year treatment with eribulin in a patient with uterine leiomyosarcoma: A case report

Uterine leiomyosarcoma (LMS) is a gynecological malignancy with an extremely poor prognosis. Multiple new therapeutic agents, including pazopanib, trabectedin, and eribulin, have been clinically applied to treat uterine LMS, and their therapeutic effects are expected. We encountered one patient with...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuura, Motoki, Yorozu, Kazuma, Nagao, Sachiko, Kurokawa, Shoko, Tamate, Masato, Akimoto, Taishi, Saito, Tsuyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238571/
https://www.ncbi.nlm.nih.gov/pubmed/37273765
http://dx.doi.org/10.1016/j.gore.2023.101205

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10238571/
https://www.ncbi.nlm.nih.gov/pubmed/37273765
http://dx.doi.org/10.1016/j.gore.2023.101205

Ejemplares similares